New York, NY · Founded 2016 · Privately Held (backing)
Developer of an implantable stent-rode designed to create a brain-computer interface. Synchron is based in New York, NY and was founded in 2016. It was valued at $385 million at its later-stage round in Dec 2022, the last priced event on record. It has raised $340 million across 1 recorded round; the latest was a $49.9 million early-stage round in Nov 2022.
PMV mark · valuation
$385.0M
Oct 2026
Priced at
its later-stage round
Dec 2022
Total raised
$339.9M
Last round
Early Stage VC
Nov 2022
Cap table — not yet on record
Synchron's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Synchron
·Every dated print: 11 trades with prices and structures
·4 investment vehicles formed around Synchron: sponsors, sizes, dates